Evidence map›Paper›PMID 28025592›Full record

ArticleCanadian respiratory journal2016

Mortality Related Risk Factors in High-Risk Pulmonary Embolism in the ICU.

Begüm Ergan, Recai Ergün, Taner Çalışkan, Kutlay Aydın, Murat Emre Tokur, Yusuf Savran, Uğur Koca, Bilgin Cömert, Necati Gökmen

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Canadian respiratory journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06833827 ('Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands'), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06833827 narecruitingnot on this mapstarted 2025, after this paper: background citation

'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL

TypeinterventionalSponsorLeiden University Medical CenterRan2025 to 2029Enrolled111ConditionsPulmonary Embolism AcuteArmsCatheter-directed thrombectomy (CDT), thrombolysis therapy
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. The Thromboembolism Heparinization and AntithrombiN Observational Study (THANOS-1).Research and practice in thrombosis and haemostasis · 2026
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Begüm ErganSchool of Medicine, Intensive Care Unit, Dokuz Eylül University, Izmir, Turkey.ORCID 0000-0003-2920-9214
Recai ErgünDışkapı Yıldırım Beyazıt Education and Research Hospital, Medical Intensive Care Unit, Ankara, Turkey.
Taner ÇalışkanSchool of Medicine, Intensive Care Unit, Dokuz Eylül University, Izmir, Turkey.
Kutlay AydınSchool of Medicine, Intensive Care Unit, Dokuz Eylül University, Izmir, Turkey.
Murat Emre TokurSchool of Medicine, Intensive Care Unit, Dokuz Eylül University, Izmir, Turkey.
Yusuf SavranSchool of Medicine, Intensive Care Unit, Dokuz Eylül University, Izmir, Turkey.ORCID 0000-0002-0130-4730
Uğur KocaSchool of Medicine, Intensive Care Unit, Dokuz Eylül University, Izmir, Turkey.ORCID 0000-0002-2949-4265
Bilgin CömertSchool of Medicine, Intensive Care Unit, Dokuz Eylül University, Izmir, Turkey.
Necati GökmenSchool of Medicine, Intensive Care Unit, Dokuz Eylül University, Izmir, Turkey.ORCID 0000-0003-1835-4133

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedFemaleHumansIntensive Care UnitsMaleMiddle AgedPulmonary EmbolismRetrospective StudiesRisk FactorsThrombolytic TherapyTurkey

Identifiers

PMID28025592
PMCPMC5153485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.